Pawliamcs. 'Dep of Clin Nuu. Un~venity of GOleborg. Sweden. B~oelccuic Impedance (BIAI conelares w~th anthrowmeuic methods as well as other methods D estimate body ;omposition in humans. In children BIA has mainly been used in nuniuonal studies, whereas hormonal influences have no1 been nud~ed. In adulls excess and deficiency of GH marLedly change Ihe body composition. Aim: The illm of Ltus study was D fmd out ~f the varialion of GH secretion in children influences their body composition measured as SIA. Material and melhods: BIA measurements (n=221) were performed at slandardizwl conditions in 189 children (140 male. 87 prepub153 pub. 81 female. 31/50) with a mean age of 11.8 (SO 3.5) and range 2.0-19.9 years: mean hc~ghl SDS of -1.09. range 4.3 to 4.4 and with a mean spontaneous Uh-GH secretion eroresxd as ceak secretion fAUC) ofGH mULR4h (ranae25-268 mURn4h).Thechildren ucrc ~nvc.\t!'~alwl dlr.10 s h t t or wll slalur< or wcrc n a n d con&ls. Only ch~lhcren u~t h sevcrp GH dcfiacnc, fAUC.< 25 mUL) were crcludd 'Ttr Whn~wl crmr 01 thc BIA mm~mcmcnl uas 2%.
Transient falls in plasma potassium (K) concentration following IGF-I iniection have oreviouslv been rewrted. However. the ~r e c i s e mechanismof this e h c t hns nevkr been in;estigated. T o adress this poini. 4 prepubertal patients (2 girls, 2 boys, aged 5 lo 14 yrs) with h r o n dwarfism have been studled. In all ~alients. ueatment with IGF-I had been withdrawn for at least 3 weeks. After an bvernight fast, a 30-min urine collection period was performed. Venous blood was drawn (through an indwelling catheter, without a tourniquet) at the mid-point of the period. After subcutaneous injection of IGF-I (provided by KABI Pharmacia, 40pg/kg B.W.), a 3-hr urine collection period was performed during which blood was sampled every 60 min. There was no significant change in venous pH, plasma bicarbonate, plasma comsol. plasma glucose. olasma insulin. and olasma elucaeon concentrations. Plasma n;~rc~ineihrine corkenmtion remained ;table a i ove;tl~e sludy. ~h e r c a s plasma epinephrine and p l a t m~ aldorlerone concentrations increased In 2 pJtlerlts but renla~ned stable in the 2 others. We conclude that: 1) ICF.1 induces 3 steeo decrease in plasma K concentration in patients with ~a r o n dwarfism 2) th; decrease in plasma K concenuation is due to an acute inuacellular K shift, since urinary K excretion did not increase 3) the IGF-I induced K shift occurs despile no significant change in the k m w n determinants of transcellular K movements, suggesting that inuacellular K shii is a direct effect of IGF-I. S e v e n t y t h r e e p e r i p u b e r t a l c h i l d r e n ( 4 9 M, 2 4 F ) w e r e s t u d i e d . H e i g h t w a s <2 8D f o r a g e a n d g e n d e r , g r o w t h v e l o c i t y w a s < 4 . 5 c m l y e a r , b o n e a g e w a s m o r e t h a n 2 SD b e l o w m e a n f o r a g e a n d GH r e s p o n s e t o p r o v o c a t i v e t e s t s ( P T ) w a s < 1 0 m c g / L i n 1 2 c h i l d r e n ( g r o u p GIID). PT w a s > 1 0 m c g / L i n 6 1 c h i l d r e n o f w h i c h 3 1 s u b j e c t s ( g r o u p T ) w e r e t r e a t e d w i t h GI1 0 . 7 5 u / k g / w e e k f o r 2-5 y e a r s , u n t i l FH w a s a t t a i n e d . 2 0 ( g r o u p C ) w e r e u n t r e a t e d c h i l d r e n who w e r e f o l l o w e d u n t i l c e s s a t i o n o f g r o w t h a n d s e r v e d a s c o n t r o l s . T h e T a n n e r -W h i t e h o u s e (TW) a n d t h e B a y l e y -P i n n e a u (BP) p r e d i c t i o n s ( i n SDS) w e r e h i g h l y c o r r e l a t e d w i t h FH i n t r e a t e d g r o u p s ( r = 0 . 7 4 7 a n d r = o . 6 4 6 , ~< o . o z ) . T h e TW a n d BP m e t h o d s o v e r e s t i m a t e d FH i n t r e a t e d g r o u p s b y 3 . 6 a n d 3 cm. T h e u n t r e a t e d g r o u p w a s s h o r t e r b y 0 . 7 SDS t h a n t h e t r e a t e
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d g r o u p s . N e i t h e r p r e t r e a t m e n t h e i g h t v e l o c i t y n o r GI1 m e a s u r e m e n t s b y p h y s i o l o g i c o r p h a r m a c o l o g i c t e s t s w e r e c o r r e l a t e d w i t h FII. T h e m a i n e f f e c t o f GH w a s o b s e r v e d d u r i n g
t h e f i r s t y e a r o f t r e a t m e n t i n g r o u p T w h e n h e i g h t v e l o c i t y w a s s i g n i f i c a n t l y h i g h e r i n t h e t h a n i n t h e u n t r e a t e d ( 9 . 3 2 2 . 1 v s 5 . 3 f l . l r e s p e c t i v e l y , p < o . o o l ) FH o f g r o u p G a n d T w e r e s i m i l a r . T h e h i g h c o s t o f t h e t r e a t m e n t i n g r o u p T s h o u l d b e w e i g h t e d a g a i n s t t h e r e s u l t s . T h e i m m u n o g e n i c i t y o f 3 r e c o m b i n a n t GH p r e p a r a t i o n s u s e d t o t r e a t 1 1 7 c h i l d r e n h a v e b e e n c o m p a r e d . C h i l d r e n w e r e 4-12 y e a r s o f a g e , 7 0 M, 4 7 F. H e i g h t < 2 SD f o r a g e a n d g e n d e r , h e i g h t v e l o c i t y < 4 . 5 c m / y e a r a n d b o n e a g e d e l a y > 2 SD f o r a g e . F i f t e e n c h i l d r e n w e r e w i t h c h r o n i c r e n a l f a i l u r e , a n d 1 0 2 w i t h g r o w t h f a i l u r e w i t h o u t k n o w n e t i o l o g y . GH r e s p o n s e t o p r o v o c -a t i v e t e s t s i n a l l c h i l d r e n w e r e > 1 0 m c s / L . T h e -.
c h i l d r e n w e r e t r e a t e d w i t h B i o -T r o p i n ( B i o -T e c h n o l o g y G e n e r a l , I s r a e l :n=55, 6 y e a r s ) , N o r d i t r o p i n (Novo-N o r d i s k , D e n m a r k ; n = 6 2 ,3-4 y r s ) a n d ~a i i e n ( s e r o n o ; n = a , 0 . 9 -1 y e a r ) . F o r t h e d e t e c t i o n o f a n t i OH a n t
i -b o d i e s ( a b ) , a d o u b l e a n t i b o d y i m m u n o a s s a y w a s u t i l i z e d . T h i r t y o f t h e s a m p l e s w e r e a n a l y z e d b y t w o d i f f e r e n t l a b o r a t o r i e s . Non o f t h e p a t i e n t s d e v e l o p e d a n t i GH a b . I t is c o n c l u d e d t h a t i n c o n t r a s t t o t h e p a s t e x p e r i e n c e w h e r e t h e d e t e c t i o n o f a n t i GH a b i n c h i l d r e n t r e a t e d w i t h d i f f e r e n t b r a n d s o f a u t h e n t i c GH w a s f r e q u e n t , t h e d e g r e e o f p u r i t y o f c o n t e m p o r a r y
p r e p a r a t i o n s p r e v e n t s d e v e l o p m e n t of a n t i GH a b .
ZADIK Z, DOVEV R PEDIATRIC ENDOCRINE UNIT, XAPLAN HOSPITAL, REHOVOT, ISRAEL ARE HEIGHTS AND WEIGHTS NORMALLY DISTRIBUTED 7 W e m e a s u r e d h e i g h t s a n d w e i g h t s o f 5 0 5 6 c h i l d r e n , f r o m b i r t h t o 1 8 y e a r s o f a g e , i n t h e v i c i n i t y s e r v e d b y o u r h o s p i t a l . On a l l c h i l d r e n b o d y m a s s i n d e x (BMI) w a s c a l c u l a t e d (~g l m~) . C h i l d r e n y o u u s e r t h a n 3 y e a r s o f a u e w e r e m e a s u r e d i n t h e ; e c & e n t o l d e r -c h i l d r e n w e r e m e a s u r e d b y a n u p r i g h t p o r t a b l e h a r p e n d e n s t a d i o m e t e r . A l l c h i l d r e n w e r e m e a s u r e d b a r e f o o t w i t h l i u h t u n d e rw e a r . A g e s i n c h i l d r e n y o u n g e r t h a n 2 w e r e c a l c u l a t e d i n 3 m o n t h s i n t e r v a l s , i n o l d e r c h i l d r e n
t h e a g e w a s c a l c u l a t e d i n y e a r l y -i n t e r v a l s . H e i g h t s w e r e n o r m a l l y d i s t r i b u t e d i n b o t h s e x e s i n a l l a g e g r o u p s . H e i g h t s w e r e n o r m a l l y d i s t r i b u t e d u p t o t h e a g e o f 6 . I n c h i l d r e n o l d e r t h a n 6 , s k e w n e s s t o t h e r i g h t i n w e i g h t s w a s n o t e d i n b o t h s e x e s . L o g t r a n s f o r m a t i o n o f w e i g h t d a t a i n c h i l d r e n o l d e r t h a n 6 y e a r s o f a g e g a v e a n o r m a l d i s t r i b u t i o n . BMI b e s t f i t t e d w i t h a 4 t h d e g r e e p o l y n o m , w e r e BHI d e c r e a s e d p r o g r e s s i v e l y u p t o t h e a g e o f 6 a n d i n c r e a s e d p r o g r e s s i v e l y t h e r e a f t e r . It i s p o s s i b l e t h a t t h e s k e w n e s s t o t l i e r i u l i t o f w e i~h t m e a s u r e m e n t s c a n b e e x p l a i n e d b y e n v i r o n m e n t a l f a c t o r s l i k e f o o d c o n s u m p t i o n h a b i t s i n a s o c i e t y i n w h i c h u n d e rn u t r i t i o n i s rare a n d o v e r f e e d i n g i s a p r o b l a m . T h i s c a n a l s o e x p l a i n t h e p r o g r e s s i v e i n c r e a s e i n BHI w h i c h c a n b e as a r e s u l t o f a g r e a t e r i n c r e a s e i n w e i g h t g a i n as o o m p a r e d t o h e i g h t g a i n . "N-T and IGF 1-GT were studled by correlating shortterm effects to subsequent growth velocity (GV) during therapy.
307
Nitrogen excretion oiing the stable isotope ' 5~ and IGF 1 were measured before and after 2 IU ~H G H /~' BW s.c. on 3 consecutive days in patients with complete growth hormone deficiency (cGHD, n=17), pattial GHD (pGHD.n=16) and normal variant short stature (NVSS,n=t8). Only cGHD and pGHD palients were treated for 1 year with rHGH (12 lu/m2xwk). Before treatment there were no Significant differences In auxdoglcal data between the 3 groups; "N-T, IGF I-GT and growth velocity (GV) were compared wkh GV in the subsequent year either wilh rHGHtherapy (cGHD and &HDI or without INVSSI. 15~-excretion was measured bv isolooe , , m a s s~e~t r o m e t r~.
IGF 1 w i s etemlned by RIA aner exiraction. Results: The effect of rHGH-administration on-the "N-T differed significantly between the 3 arouos. The best response (143~6.9% 15~-retentlon) was seen in the-CGHD group. while i30.1~16.496 (p<0.001) In the pGHD and 108.9~6.4% (pc0,OOi)ln the NVSS group were reached. The IGF 1 -GT did no1 show anv dfflerences between the three orouDs of oatients. After 1 vsar of , -rnGh tnerapy GV was 11 3 1 3 cm/a n the cGH0 and 7 ir2i cmja In the phGH group Tne GV In the untreated NVSS ~alienls was s on11 cantlv lower I4 2 + 1 7 cmlal comoard to the cGHD (pc0,Wt) and the pGHD (p<0:001) paiients i h ' e T 5 N -~ dak disdriminate between patients with complete and partial GHD and patients with short stature after only 3 lnlections of rHGH. A correlation between 15~.T and GV after 1 year of rHGH treatment was seen in the pGHD group (r=0.87). IGF 1-GT as well GV before treatment were not suitable to predict growth hormone response in any group. Gonclusions: in this study the l 5~. T was reliable In differentiating the 3 groups of patients and in predicting the response to growth hormone treatment In patients wfih pGHD
